Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | William D. Tap, Robin L Jones, Bartosz Chmielowski, Anthony D. Elias, Douglas Adkins, Brian Andrew Van Tine, Mark Agulnik, Matthew M. Cooney, Michael B. Livingston, Gregory K. Pennock, Amy Qin, Ashwin Shahir, Robert L. Ilaria, Ilaria Conti, Jan Cosaert | ||||||||||||
Title | A randomized phase Ib/II study evaluating the safety and efficacy of olaratumab (IMC-3G3), a human anti-platelet-derived growth factor ? (PDGFR?) monoclonal antibody, with or without doxorubicin (Dox), in advanced soft tissue sarcoma (STS). | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/147332-156 | ||||||||||||
Abstract Text | J Clin Oncol 33, 2015 (suppl; abstr 10501) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|